History of PharmaBio Labs
PharmaBio Labs LLC was set up in 2021 in the United States to enable a group of companies created since 2008 by Dr. Raymond M. Abolhassani with the main operations starting in France but then expanding in different countries.
The core value of PharmaBio Labs is in the production of BCG biomass in France capitalizing on Dr. Abolhassani’s 35 years academic and commercial experience including at Institut Pasteur in Paris, where BCG vaccine was first created 100 years ago.
PharmaBio Labs LLC was created in the United States as part of an international restructuring of its operation that will include a pursue of a listing in a US stock exchange, potentially with a merger into a Special Purpose Acquisition Company (SPAC).
